Foundation Fighting Blindness Retinal Degeneration Fund 4
4 · Opus Genetics, Inc. · Filed May 6, 2025
Insider Transaction Report
Form 4
Foundation Fighting Blindness Retinal Degeneration Fund
Director10% OwnerOther
Transactions
- Conversion
Series A Non-Voting Convertible Preferred Stock
2025-05-05−6,927.419→ 0 totalFrom: 2025-05-05→ Common Stock (6,927,419 underlying) - Conversion
Common Stock
2025-05-05+6,927,419→ 9,492,171 total
Footnotes (3)
- [F1]Each share of Series A non-voting convertible preferred stock (the "Preferred Stock") automatically converted into 1,000 shares of the Issuer's common stock as of 5:00 p.m. Eastern time on the third business day after the date that the Issuer's stockholders approved the conversion of the Preferred Stock into shares of the Issuer's common stock, which approval occurred on April 30, 2025.
- [F2]Foundation Fighting Blindness, Inc. ("FFB") is the sole member of Foundation Fighting Blindness Retinal Degeneration Fund ("RDF") and may be deemed to beneficially own the securities owned directly by RDF. RDF has the power to vote and dispose of any securities directly owned by RDF. RDF's board of directors makes voting and investment decisions regarding securities held by RDF, subject to certain approval rights of the board of directors of FFB with respect to transactions exceeding a certain threshold.
- [F3]The shares of Preferred Stock were issued to the Reporting Persons in connection with a merger and reorganization in a stock-for-stock transaction.